Trials / Recruiting
RecruitingNCT07222410
Closed Loop Oxygen Control in Chronic Obstructive Pulmonary Disease (COPD) Patients Treated With Nasal High Flow in the Hospital
Closed Loop Oxygen Control in COPD Patients Treated With Nasal High Flow in the Hospital
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 70 (estimated)
- Sponsor
- Fisher and Paykel Healthcare · Industry
- Sex
- All
- Age
- 22 Years
- Healthy volunteers
- Not accepted
Summary
The trial aims to evaluate whether the Airvo 3 device in OptiO2 mode can maintain patients' SpO2 levels within the target range better than manual oxygen titration in hospitalized COPD patients with hypoxemia/respiratory distress.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Closed loop oxygen control | Nasal high flow with closed loop oxygen control |
| DEVICE | Manual titration | Nasal high flow with manual titration |
Timeline
- Start date
- 2026-01-07
- Primary completion
- 2027-11-01
- Completion
- 2027-11-01
- First posted
- 2025-10-29
- Last updated
- 2026-01-12
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT07222410. Inclusion in this directory is not an endorsement.